Bone mineral density increases with raloxifene in postmenopausal women

Administration of raloxifene at varying doses (30 mg, black dashed line; 60 mg, green line; 150 mg, blue dotted line) resulted in an increase in bone mineral density compared with placebo (black dotted line) in all sites tested over the two-year follow-up period.